Muutke küpsiste eelistusi

E-raamat: Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 1: Cardiovascular Diseases

  • Formaat: PDF+DRM
  • Ilmumisaeg: 14-Apr-2026
  • Kirjastus: Apple Academic Press Inc.
  • Keel: eng
  • ISBN-13: 9781040915585
  • Formaat - PDF+DRM
  • Hind: 182,00 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: PDF+DRM
  • Ilmumisaeg: 14-Apr-2026
  • Kirjastus: Apple Academic Press Inc.
  • Keel: eng
  • ISBN-13: 9781040915585

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Pharmacists are increasingly recognized not just as dispensers of medications but as key healthcare providers offering a wide range of services. At present, there is no comprehensive resource on the evidence-based practice of the clinical, economic, and humanistic impact of pharmacist care that discusses the implications and challenges and that provides practical tips for effective pharmacist care services. And there is no book that discusses online and distance pharmacist care.

Recognizing that the value of pharmacists extends beyond clinical interventions to include cost-effective healthcare solutions and compassionate, patient-centered care, this new series of handbooks aims to fill this gap by showcasing the expanded roles and responsibilities of pharmacists. It will be first of its kind to provide comprehensive information about evidence-based pharmacist care, providing the latest research, guidelines, and up-to-date best practices.

This handbook series is unique in that each volume covers a specific topic, such as infectious diseases, gastrointestinal diseases, and cardiovascular diseases (to name just three areas) and will explore the impact of pharmacist care on patients in clinical settings, consider the economics and humanistic outcomes, as well as discuss the challenges and present helpful advice for implementing effective pharmacist care. The volumes will also delve into the implications, methods, and challenges of providing online and distance pharmacist care services for the specific diseases and conditions as well.

The first volume in the series, Volume 1: Cardiovascular Diseases, offers an in-depth look at the multifaceted and critical role pharmacists play in managing cardiovascular diseases, a domain where the pharmacist role is both critical and transformative. By focusing on conditions such as hypertension, hyperlipidemia, angina, myocardial infarction, heart failure, arrhythmias, thrombosis, and shock, the volume presents a holistic view of the clinical, economical, and humanistic impact of pharmacists in cardiovascular care. Each chapter in this book presents the latest research, guidelines, and up-to-date best practices and provides evidence-based insights into the management of these conditions, emphasizing the pharmacist role in optimizing therapeutic outcomes. A distinctive feature of this book is its emphasis on the economic and humanistic aspects of pharmacist care and its recognition of the value of pharmacists extends beyond clinical interventions to include cost-effective healthcare solutions and compassionate, patient-centered care. This approach is particularly crucial in managing chronic conditions like cardiovascular diseases, where long-term therapy and patient adherence play vital roles.

Volumes in Handbook of Evidence-Based Pharmacist Care<

Volume 1: Cardiovascular Diseases

Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders

Volume 3: Gastrointestinal Diseases and Disorders

Volume 4: Arthritis and Psychiatric Diseases and Disorders

Volume 5: System-Specific Infections

Volume 6: Widespread and Transmissible Infections

Volume 7: Skin Diseases and Conditions

Volume 8: Neurological, Hematological, and Urological Diseases and Disorders

Volume 9: Oncological Diseases and Disorders

Volume 10: Diseases and Disorders of Special Populations

Volume 11: Pharmacist Care in Special Services

Volume 12: Advanced Practices in Pharmacist Care

Volume 13: Pharmacist Skills and Competencies

Volume 14: Clinical Pharmacy, Advanced Pharmacist Practice, and Pharmacy Clinics: Case Studies from Around the World



An in-depth look at the multifaceted and critical role of pharmacists in managing cardiovascular diseases, focusing hypertension, hyperlipidemia, angina, myocardial infarction, heart failure, arrhythmias, thrombosis, and shock. Presents the latest research, guidelines, and up-to-date best practices.

1. Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic
Impact): Hypertension
2. Evidence-Based Pharmacist Care (Clinical, Economic,
and Humanistic Impact): Hyperlipidemia
3. Evidence-Based Pharmacist Care
(Clinical, Economic, and Humanistic Impact): Angina
4. Evidence-Based
Pharmacist Care (Clinical, Economic, and Humanistic Impact): Myocardial
Infarction
5. Evidence-Based Pharmacist Care (Clinical, Economic, and
Humanistic Impact): Arrhythmias
6. Evidence-Based Pharmacist Care (Clinical,
Economic, and Humanistic Impact): Thrombosis
7. Evidence-Based Pharmacist
Care (Clinical, Economic, and Humanistic Impact): Shock
Yaser Mohammed Al-Worafi, PhD, FRSPH (UK), is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, United Arab Emirates. He has more than 20 years of experience in education, practice, research, and administration in Yemen, Saudi Arabia, United Arab Emirates, and Malaysia, having taught, prepared, designed, and written courses and programs for many universities on clinical pharmacy, pharmacy practice, social pharmacy, and patient care. He has authored over 100 peer-reviewed papers in international journals and book chapters and has edited more than 30 books. A fellow of the Royal Society of Public Health, UK, Prof. Yaser has been recognized globally for his contributions to pharmacy practice, education, and medication and patient safety and is listed as one of the Top 2% Scientists of the World by Stanford University. He is ranked among the best ten researchers globally in several key areas, highlighting his dedication and expertise in advancing medication safety and effectiveness.